Literature DB >> 7749820

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

R A Hegele1, J H Brunt, P W Connelly.   

Abstract

The Hutterite Brethren are a genetic isolate characterized by high indices of relatedness and a communal agrarian lifestyle. We hypothesized that variation of the paraoxonase (PON) gene that underlies the interindividual variation in plasma PON activity would be associated with variation in fasting plasma lipoprotein variables in this group. In 793 Hutterites, we measured plasma lipids, lipoproteins, and apolipoproteins and analyzed DNA for genotypes of the protein polymorphism at amino acid residue 192 of PON. We observed that genotypes of PON were significantly associated with variation in plasma concentrations of total, HDL, non-HDL, and LDL cholesterol, total triglycerides, and apolipoprotein (apo) B. Homozygotes for the low-activity variant of PON had significantly lower levels of plasma apoB-related biochemical variables than heterozygotes and homozygotes for the high-activity variant of PON. Homozygotes for the low-activity variant of PON also had significantly lower ratios of total cholesterol/HDL cholesterol, LDL cholesterol/HDL cholesterol, and apoB/apoA-I than heterozygotes and homozygotes for the high-activity variant of PON. We found no evidence for a gene-gender interaction for any plasma lipoprotein variable. The PON polymorphism accounted for about 1% of the variation in total cholesterol and related lipoprotein traits in the Hutterites. These observations suggest that PON is a significant genetic determinant of plasma lipoprotein levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749820     DOI: 10.1161/01.atv.15.1.89

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

Authors:  M C Garin; R W James; P Dussoix; H Blanché; P Passa; P Froguel; J Ruiz
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

3.  Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Authors:  Maria Fernanda Martínez-Salazar; Damianys Almenares-López; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Alina Juantorena-Ugás; Camilo Ríos; Antonio Monroy-Noyola
Journal:  Genes Nutr       Date:  2011-03-25       Impact factor: 5.523

4.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.

Authors:  M Antikainen; S Murtomäki; M Syvänne; R Pahlman; E Tahvanainen; M Jauhiainen; M H Frick; C Ehnholm
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

6.  Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.

Authors:  Yi Han; Rajkumar Dorajoo; Tingjing Ke; Burger Ayala; Xuling Chang; Chiea-Chuen Khor; Rob M van Dam; Jian-Min Yuan; Woon-Puay Koh; Jianjun Liu; Daniel Y T Goh; Yechiel Friedlander; Chew-Kiat Heng
Journal:  Atherosclerosis       Date:  2015-02-25       Impact factor: 5.162

7.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Authors:  L W Castellani; M Navab; B J Van Lenten; C C Hedrick; S Y Hama; A M Goto; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

8.  Paraoxonase 1 status in the Thai population.

Authors:  Wimon Phuntuwate; Chuthamanee Suthisisang; Banhan Koanantakul; Michael I Mackness; Bharti Mackness
Journal:  J Hum Genet       Date:  2005-05-28       Impact factor: 3.172

9.  The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.

Authors:  Mohammed A Hassan; Omar S Al-Attas; Tajamul Hussain; Nasser M Al-Daghri; Majed S Alokail; Abdul K Mohammed; Benjamin Vinodson
Journal:  Mol Cell Biochem       Date:  2013-04-27       Impact factor: 3.396

10.  Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease.

Authors:  Makbule Aydin; Cahide Gokkusu; Elif Ozkok; Feti Tulubas; Yesim Unlucerci; Burak Pamukcu; Zeynep Ozbek; Berrin Umman
Journal:  Mol Cell Biochem       Date:  2009-02-14       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.